No abstract available
MeSH terms
-
Anaplastic Lymphoma Kinase
-
Antineoplastic Agents / pharmacology*
-
Antineoplastic Agents / therapeutic use
-
Clinical Trials as Topic
-
Crizotinib
-
Female
-
Gene Amplification* / drug effects
-
Humans
-
Inflammatory Breast Neoplasms / drug therapy*
-
Inflammatory Breast Neoplasms / genetics*
-
Molecular Targeted Therapy* / methods
-
Pyrazoles / pharmacology*
-
Pyrazoles / therapeutic use
-
Pyridines / pharmacology*
-
Pyridines / therapeutic use
-
Receptor Protein-Tyrosine Kinases / drug effects
-
Receptor Protein-Tyrosine Kinases / genetics*
Substances
-
Antineoplastic Agents
-
Pyrazoles
-
Pyridines
-
Crizotinib
-
ALK protein, human
-
Anaplastic Lymphoma Kinase
-
Receptor Protein-Tyrosine Kinases